nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2E1—Fingolimod—multiple sclerosis	0.11	0.172	CbGbCtD
Etoricoxib—PTGS2—Triamcinolone—multiple sclerosis	0.0823	0.128	CbGbCtD
Etoricoxib—PTGS2—Betamethasone—multiple sclerosis	0.0706	0.11	CbGbCtD
Etoricoxib—CYP2D6—Fingolimod—multiple sclerosis	0.0524	0.0818	CbGbCtD
Etoricoxib—CYP2E1—Mitoxantrone—multiple sclerosis	0.0517	0.0807	CbGbCtD
Etoricoxib—PTGS2—Dexamethasone—multiple sclerosis	0.0411	0.0641	CbGbCtD
Etoricoxib—CYP3A4—Fingolimod—multiple sclerosis	0.0333	0.052	CbGbCtD
Etoricoxib—CYP2C19—Prednisone—multiple sclerosis	0.0269	0.042	CbGbCtD
Etoricoxib—CYP2E1—Dexamethasone—multiple sclerosis	0.0268	0.0418	CbGbCtD
Etoricoxib—CYP3A4—Methylprednisolone—multiple sclerosis	0.0215	0.0335	CbGbCtD
Etoricoxib—CYP2C19—Dexamethasone—multiple sclerosis	0.0168	0.0262	CbGbCtD
Etoricoxib—CYP3A4—Triamcinolone—multiple sclerosis	0.0163	0.0254	CbGbCtD
Etoricoxib—CYP3A4—Mitoxantrone—multiple sclerosis	0.0157	0.0244	CbGbCtD
Etoricoxib—CYP2C9—Dexamethasone—multiple sclerosis	0.014	0.0218	CbGbCtD
Etoricoxib—CYP3A4—Betamethasone—multiple sclerosis	0.014	0.0218	CbGbCtD
Etoricoxib—CYP3A4—Prednisolone—multiple sclerosis	0.0138	0.0215	CbGbCtD
Etoricoxib—CYP3A4—Prednisone—multiple sclerosis	0.013	0.0203	CbGbCtD
Etoricoxib—CYP2D6—Dexamethasone—multiple sclerosis	0.0128	0.0199	CbGbCtD
Etoricoxib—CYP3A4—Dexamethasone—multiple sclerosis	0.00812	0.0127	CbGbCtD
Etoricoxib—Vemurafenib—ALB—multiple sclerosis	0.00153	0.478	CrCbGaD
Etoricoxib—Celecoxib—ALB—multiple sclerosis	0.000897	0.281	CrCbGaD
Etoricoxib—Vismodegib—ALB—multiple sclerosis	0.000769	0.241	CrCbGaD
Etoricoxib—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000759	0.159	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000747	0.156	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000747	0.156	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.00073	0.153	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000458	0.0957	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000451	0.0942	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000451	0.0942	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00044	0.0921	CbGdCrCtD
Etoricoxib—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000162	0.000755	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000161	0.000752	CcSEcCtD
Etoricoxib—Shock—Prednisolone—multiple sclerosis	0.00016	0.000745	CcSEcCtD
Etoricoxib—Cough—Triamcinolone—multiple sclerosis	0.00016	0.000745	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000159	0.000738	CcSEcCtD
Etoricoxib—Hypertension—Triamcinolone—multiple sclerosis	0.000158	0.000737	CcSEcCtD
Etoricoxib—Hypertension—Methylprednisolone—multiple sclerosis	0.000158	0.000735	CcSEcCtD
Etoricoxib—Urticaria—Mitoxantrone—multiple sclerosis	0.000157	0.000733	CcSEcCtD
Etoricoxib—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000157	0.00073	CcSEcCtD
Etoricoxib—Vomiting—Azathioprine—multiple sclerosis	0.000156	0.000726	CcSEcCtD
Etoricoxib—Pneumonia—Methotrexate—multiple sclerosis	0.000156	0.000725	CcSEcCtD
Etoricoxib—Arthralgia—Methylprednisolone—multiple sclerosis	0.000156	0.000725	CcSEcCtD
Etoricoxib—Eye disorder—Prednisone—multiple sclerosis	0.000155	0.000724	CcSEcCtD
Etoricoxib—Anxiety—Methylprednisolone—multiple sclerosis	0.000155	0.000722	CcSEcCtD
Etoricoxib—Infestation NOS—Methotrexate—multiple sclerosis	0.000155	0.000721	CcSEcCtD
Etoricoxib—Infestation—Methotrexate—multiple sclerosis	0.000155	0.000721	CcSEcCtD
Etoricoxib—Rash—Azathioprine—multiple sclerosis	0.000155	0.00072	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000155	0.00072	CcSEcCtD
Etoricoxib—Dermatitis—Azathioprine—multiple sclerosis	0.000154	0.000719	CcSEcCtD
Etoricoxib—Flushing—Prednisone—multiple sclerosis	0.000154	0.000719	CcSEcCtD
Etoricoxib—Headache—Azathioprine—multiple sclerosis	0.000154	0.000715	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000154	0.000715	CcSEcCtD
Etoricoxib—Dry mouth—Triamcinolone—multiple sclerosis	0.000153	0.000711	CcSEcCtD
Etoricoxib—Renal failure—Methotrexate—multiple sclerosis	0.000152	0.000709	CcSEcCtD
Etoricoxib—Angioedema—Betamethasone—multiple sclerosis	0.000152	0.000708	CcSEcCtD
Etoricoxib—Angioedema—Dexamethasone—multiple sclerosis	0.000152	0.000708	CcSEcCtD
Etoricoxib—Stomatitis—Methotrexate—multiple sclerosis	0.000151	0.000703	CcSEcCtD
Etoricoxib—Angiopathy—Prednisone—multiple sclerosis	0.000151	0.000703	CcSEcCtD
Etoricoxib—Conjunctivitis—Methotrexate—multiple sclerosis	0.000151	0.000701	CcSEcCtD
Etoricoxib—Confusional state—Methylprednisolone—multiple sclerosis	0.00015	0.000701	CcSEcCtD
Etoricoxib—Immune system disorder—Prednisone—multiple sclerosis	0.00015	0.0007	CcSEcCtD
Etoricoxib—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00015	0.000697	CcSEcCtD
Etoricoxib—Oedema—Triamcinolone—multiple sclerosis	0.00015	0.000697	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000149	0.000695	CcSEcCtD
Etoricoxib—Arrhythmia—Prednisone—multiple sclerosis	0.000149	0.000692	CcSEcCtD
Etoricoxib—Infection—Triamcinolone—multiple sclerosis	0.000149	0.000692	CcSEcCtD
Etoricoxib—Infection—Methylprednisolone—multiple sclerosis	0.000148	0.00069	CcSEcCtD
Etoricoxib—Haematuria—Methotrexate—multiple sclerosis	0.000148	0.000688	CcSEcCtD
Etoricoxib—Shock—Triamcinolone—multiple sclerosis	0.000147	0.000685	CcSEcCtD
Etoricoxib—Insomnia—Prednisolone—multiple sclerosis	0.000147	0.000685	CcSEcCtD
Etoricoxib—Alopecia—Prednisone—multiple sclerosis	0.000147	0.000685	CcSEcCtD
Etoricoxib—Shock—Methylprednisolone—multiple sclerosis	0.000147	0.000684	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000146	0.000682	CcSEcCtD
Etoricoxib—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000146	0.000682	CcSEcCtD
Etoricoxib—Epistaxis—Methotrexate—multiple sclerosis	0.000146	0.00068	CcSEcCtD
Etoricoxib—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000146	0.00068	CcSEcCtD
Etoricoxib—Mental disorder—Prednisone—multiple sclerosis	0.000146	0.000679	CcSEcCtD
Etoricoxib—Nausea—Azathioprine—multiple sclerosis	0.000146	0.000678	CcSEcCtD
Etoricoxib—Skin disorder—Methylprednisolone—multiple sclerosis	0.000145	0.000675	CcSEcCtD
Etoricoxib—Malnutrition—Prednisone—multiple sclerosis	0.000145	0.000674	CcSEcCtD
Etoricoxib—Erythema—Prednisone—multiple sclerosis	0.000145	0.000674	CcSEcCtD
Etoricoxib—Hypertension—Dexamethasone—multiple sclerosis	0.000144	0.000669	CcSEcCtD
Etoricoxib—Hypertension—Betamethasone—multiple sclerosis	0.000144	0.000669	CcSEcCtD
Etoricoxib—Asthenia—Mitoxantrone—multiple sclerosis	0.000142	0.000662	CcSEcCtD
Etoricoxib—Anxiety—Dexamethasone—multiple sclerosis	0.000141	0.000657	CcSEcCtD
Etoricoxib—Anxiety—Betamethasone—multiple sclerosis	0.000141	0.000657	CcSEcCtD
Etoricoxib—Haemoglobin—Methotrexate—multiple sclerosis	0.00014	0.000651	CcSEcCtD
Etoricoxib—Pain—Prednisolone—multiple sclerosis	0.000139	0.000648	CcSEcCtD
Etoricoxib—Hepatitis—Methotrexate—multiple sclerosis	0.000139	0.000647	CcSEcCtD
Etoricoxib—Haemorrhage—Methotrexate—multiple sclerosis	0.000139	0.000647	CcSEcCtD
Etoricoxib—Pharyngitis—Methotrexate—multiple sclerosis	0.000138	0.000643	CcSEcCtD
Etoricoxib—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000137	0.000639	CcSEcCtD
Etoricoxib—Vision blurred—Prednisone—multiple sclerosis	0.000136	0.000636	CcSEcCtD
Etoricoxib—Urethral disorder—Methotrexate—multiple sclerosis	0.000136	0.000635	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000136	0.000635	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000136	0.000633	CcSEcCtD
Etoricoxib—Oedema—Betamethasone—multiple sclerosis	0.000136	0.000632	CcSEcCtD
Etoricoxib—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000136	0.000632	CcSEcCtD
Etoricoxib—Oedema—Dexamethasone—multiple sclerosis	0.000136	0.000632	CcSEcCtD
Etoricoxib—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000136	0.000632	CcSEcCtD
Etoricoxib—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000136	0.000632	CcSEcCtD
Etoricoxib—Insomnia—Triamcinolone—multiple sclerosis	0.000135	0.00063	CcSEcCtD
Etoricoxib—Insomnia—Methylprednisolone—multiple sclerosis	0.000135	0.000629	CcSEcCtD
Etoricoxib—Infection—Dexamethasone—multiple sclerosis	0.000135	0.000628	CcSEcCtD
Etoricoxib—Infection—Betamethasone—multiple sclerosis	0.000135	0.000628	CcSEcCtD
Etoricoxib—Feeling abnormal—Prednisolone—multiple sclerosis	0.000134	0.000624	CcSEcCtD
Etoricoxib—Visual impairment—Methotrexate—multiple sclerosis	0.000134	0.000624	CcSEcCtD
Etoricoxib—Anaemia—Prednisone—multiple sclerosis	0.000134	0.000623	CcSEcCtD
Etoricoxib—Shock—Betamethasone—multiple sclerosis	0.000134	0.000622	CcSEcCtD
Etoricoxib—Shock—Dexamethasone—multiple sclerosis	0.000134	0.000622	CcSEcCtD
Etoricoxib—Dyspnoea—Triamcinolone—multiple sclerosis	0.000133	0.000621	CcSEcCtD
Etoricoxib—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000133	0.00062	CcSEcCtD
Etoricoxib—Nervous system disorder—Betamethasone—multiple sclerosis	0.000133	0.00062	CcSEcCtD
Etoricoxib—Agitation—Prednisone—multiple sclerosis	0.000133	0.00062	CcSEcCtD
Etoricoxib—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000133	0.000619	CcSEcCtD
Etoricoxib—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000133	0.000619	CcSEcCtD
Etoricoxib—Angioedema—Prednisone—multiple sclerosis	0.000132	0.000616	CcSEcCtD
Etoricoxib—Dyspepsia—Triamcinolone—multiple sclerosis	0.000132	0.000613	CcSEcCtD
Etoricoxib—Erythema multiforme—Methotrexate—multiple sclerosis	0.000131	0.000612	CcSEcCtD
Etoricoxib—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000131	0.000612	CcSEcCtD
Etoricoxib—Eye disorder—Methotrexate—multiple sclerosis	0.00013	0.000605	CcSEcCtD
Etoricoxib—Tinnitus—Methotrexate—multiple sclerosis	0.00013	0.000604	CcSEcCtD
Etoricoxib—Anorexia—Betamethasone—multiple sclerosis	0.000129	0.000602	CcSEcCtD
Etoricoxib—Anorexia—Dexamethasone—multiple sclerosis	0.000129	0.000602	CcSEcCtD
Etoricoxib—Urticaria—Prednisolone—multiple sclerosis	0.000129	0.000602	CcSEcCtD
Etoricoxib—Cardiac disorder—Methotrexate—multiple sclerosis	0.000129	0.000601	CcSEcCtD
Etoricoxib—Fatigue—Triamcinolone—multiple sclerosis	0.000129	0.000601	CcSEcCtD
Etoricoxib—Fatigue—Methylprednisolone—multiple sclerosis	0.000129	0.000599	CcSEcCtD
Etoricoxib—Pain—Triamcinolone—multiple sclerosis	0.000128	0.000596	CcSEcCtD
Etoricoxib—Angiopathy—Methotrexate—multiple sclerosis	0.000126	0.000587	CcSEcCtD
Etoricoxib—Vomiting—Mitoxantrone—multiple sclerosis	0.000126	0.000587	CcSEcCtD
Etoricoxib—Immune system disorder—Methotrexate—multiple sclerosis	0.000126	0.000585	CcSEcCtD
Etoricoxib—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000125	0.000584	CcSEcCtD
Etoricoxib—Hypertension—Prednisone—multiple sclerosis	0.000125	0.000582	CcSEcCtD
Etoricoxib—Rash—Mitoxantrone—multiple sclerosis	0.000125	0.000582	CcSEcCtD
Etoricoxib—Dermatitis—Mitoxantrone—multiple sclerosis	0.000125	0.000582	CcSEcCtD
Etoricoxib—Headache—Mitoxantrone—multiple sclerosis	0.000124	0.000578	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000124	0.000576	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000124	0.000576	CcSEcCtD
Etoricoxib—Arthralgia—Prednisone—multiple sclerosis	0.000123	0.000574	CcSEcCtD
Etoricoxib—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000123	0.000574	CcSEcCtD
Etoricoxib—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000123	0.000573	CcSEcCtD
Etoricoxib—Anxiety—Prednisone—multiple sclerosis	0.000123	0.000572	CcSEcCtD
Etoricoxib—Alopecia—Methotrexate—multiple sclerosis	0.000123	0.000572	CcSEcCtD
Etoricoxib—Insomnia—Dexamethasone—multiple sclerosis	0.000123	0.000572	CcSEcCtD
Etoricoxib—Insomnia—Betamethasone—multiple sclerosis	0.000123	0.000572	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000122	0.00057	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000122	0.000568	CcSEcCtD
Etoricoxib—Mental disorder—Methotrexate—multiple sclerosis	0.000122	0.000567	CcSEcCtD
Etoricoxib—Erythema—Methotrexate—multiple sclerosis	0.000121	0.000564	CcSEcCtD
Etoricoxib—Malnutrition—Methotrexate—multiple sclerosis	0.000121	0.000564	CcSEcCtD
Etoricoxib—Hypersensitivity—Prednisolone—multiple sclerosis	0.00012	0.000558	CcSEcCtD
Etoricoxib—Dyspepsia—Dexamethasone—multiple sclerosis	0.000119	0.000556	CcSEcCtD
Etoricoxib—Dyspepsia—Betamethasone—multiple sclerosis	0.000119	0.000556	CcSEcCtD
Etoricoxib—Urticaria—Triamcinolone—multiple sclerosis	0.000119	0.000553	CcSEcCtD
Etoricoxib—Urticaria—Methylprednisolone—multiple sclerosis	0.000119	0.000552	CcSEcCtD
Etoricoxib—Dysgeusia—Methotrexate—multiple sclerosis	0.000119	0.000552	CcSEcCtD
Etoricoxib—Oedema—Prednisone—multiple sclerosis	0.000118	0.00055	CcSEcCtD
Etoricoxib—Anaphylactic shock—Prednisone—multiple sclerosis	0.000118	0.00055	CcSEcCtD
Etoricoxib—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000118	0.000549	CcSEcCtD
Etoricoxib—Decreased appetite—Betamethasone—multiple sclerosis	0.000118	0.000549	CcSEcCtD
Etoricoxib—Decreased appetite—Dexamethasone—multiple sclerosis	0.000118	0.000549	CcSEcCtD
Etoricoxib—Nausea—Mitoxantrone—multiple sclerosis	0.000118	0.000548	CcSEcCtD
Etoricoxib—Infection—Prednisone—multiple sclerosis	0.000117	0.000547	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000117	0.000546	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000117	0.000546	CcSEcCtD
Etoricoxib—Fatigue—Dexamethasone—multiple sclerosis	0.000117	0.000545	CcSEcCtD
Etoricoxib—Fatigue—Betamethasone—multiple sclerosis	0.000117	0.000545	CcSEcCtD
Etoricoxib—Shock—Prednisone—multiple sclerosis	0.000116	0.000542	CcSEcCtD
Etoricoxib—Pain—Dexamethasone—multiple sclerosis	0.000116	0.00054	CcSEcCtD
Etoricoxib—Pain—Betamethasone—multiple sclerosis	0.000116	0.00054	CcSEcCtD
Etoricoxib—Nervous system disorder—Prednisone—multiple sclerosis	0.000116	0.00054	CcSEcCtD
Etoricoxib—Skin disorder—Prednisone—multiple sclerosis	0.000115	0.000535	CcSEcCtD
Etoricoxib—Vision blurred—Methotrexate—multiple sclerosis	0.000114	0.000531	CcSEcCtD
Etoricoxib—Anorexia—Prednisone—multiple sclerosis	0.000113	0.000525	CcSEcCtD
Etoricoxib—Anaemia—Methotrexate—multiple sclerosis	0.000112	0.000521	CcSEcCtD
Etoricoxib—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000112	0.000521	CcSEcCtD
Etoricoxib—Feeling abnormal—Betamethasone—multiple sclerosis	0.000112	0.000521	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000111	0.000517	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000111	0.000517	CcSEcCtD
Etoricoxib—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00011	0.000513	CcSEcCtD
Etoricoxib—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00011	0.000512	CcSEcCtD
Etoricoxib—Urticaria—Dexamethasone—multiple sclerosis	0.000108	0.000502	CcSEcCtD
Etoricoxib—Urticaria—Betamethasone—multiple sclerosis	0.000108	0.000502	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000108	0.000501	CcSEcCtD
Etoricoxib—Dizziness—Prednisolone—multiple sclerosis	0.000108	0.000501	CcSEcCtD
Etoricoxib—Asthenia—Triamcinolone—multiple sclerosis	0.000107	0.0005	CcSEcCtD
Etoricoxib—Abdominal pain—Dexamethasone—multiple sclerosis	0.000107	0.0005	CcSEcCtD
Etoricoxib—Abdominal pain—Betamethasone—multiple sclerosis	0.000107	0.0005	CcSEcCtD
Etoricoxib—Asthenia—Methylprednisolone—multiple sclerosis	0.000107	0.000499	CcSEcCtD
Etoricoxib—Insomnia—Prednisone—multiple sclerosis	0.000107	0.000498	CcSEcCtD
Etoricoxib—Pruritus—Triamcinolone—multiple sclerosis	0.000106	0.000493	CcSEcCtD
Etoricoxib—Cough—Methotrexate—multiple sclerosis	0.000106	0.000492	CcSEcCtD
Etoricoxib—Pruritus—Methylprednisolone—multiple sclerosis	0.000106	0.000492	CcSEcCtD
Etoricoxib—Dyspepsia—Prednisone—multiple sclerosis	0.000104	0.000484	CcSEcCtD
Etoricoxib—Chest pain—Methotrexate—multiple sclerosis	0.000103	0.00048	CcSEcCtD
Etoricoxib—Arthralgia—Methotrexate—multiple sclerosis	0.000103	0.00048	CcSEcCtD
Etoricoxib—Decreased appetite—Prednisone—multiple sclerosis	0.000103	0.000478	CcSEcCtD
Etoricoxib—Rash—Prednisolone—multiple sclerosis	0.000103	0.000478	CcSEcCtD
Etoricoxib—Dermatitis—Prednisolone—multiple sclerosis	0.000102	0.000477	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000102	0.000477	CcSEcCtD
Etoricoxib—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000102	0.000476	CcSEcCtD
Etoricoxib—Fatigue—Prednisone—multiple sclerosis	0.000102	0.000475	CcSEcCtD
Etoricoxib—Headache—Prednisolone—multiple sclerosis	0.000102	0.000475	CcSEcCtD
Etoricoxib—Constipation—Prednisone—multiple sclerosis	0.000101	0.000471	CcSEcCtD
Etoricoxib—Confusional state—Methotrexate—multiple sclerosis	9.96e-05	0.000464	CcSEcCtD
Etoricoxib—Dizziness—Triamcinolone—multiple sclerosis	9.89e-05	0.000461	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methotrexate—multiple sclerosis	9.88e-05	0.00046	CcSEcCtD
Etoricoxib—Dizziness—Methylprednisolone—multiple sclerosis	9.87e-05	0.00046	CcSEcCtD
Etoricoxib—Infection—Methotrexate—multiple sclerosis	9.81e-05	0.000457	CcSEcCtD
Etoricoxib—Feeling abnormal—Prednisone—multiple sclerosis	9.74e-05	0.000454	CcSEcCtD
Etoricoxib—Asthenia—Betamethasone—multiple sclerosis	9.74e-05	0.000453	CcSEcCtD
Etoricoxib—Asthenia—Dexamethasone—multiple sclerosis	9.74e-05	0.000453	CcSEcCtD
Etoricoxib—Nervous system disorder—Methotrexate—multiple sclerosis	9.69e-05	0.000451	CcSEcCtD
Etoricoxib—Thrombocytopenia—Methotrexate—multiple sclerosis	9.67e-05	0.00045	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Prednisone—multiple sclerosis	9.66e-05	0.00045	CcSEcCtD
Etoricoxib—Nausea—Prednisolone—multiple sclerosis	9.66e-05	0.00045	CcSEcCtD
Etoricoxib—Pruritus—Betamethasone—multiple sclerosis	9.6e-05	0.000447	CcSEcCtD
Etoricoxib—Pruritus—Dexamethasone—multiple sclerosis	9.6e-05	0.000447	CcSEcCtD
Etoricoxib—Skin disorder—Methotrexate—multiple sclerosis	9.59e-05	0.000447	CcSEcCtD
Etoricoxib—Vomiting—Triamcinolone—multiple sclerosis	9.51e-05	0.000443	CcSEcCtD
Etoricoxib—Vomiting—Methylprednisolone—multiple sclerosis	9.49e-05	0.000442	CcSEcCtD
Etoricoxib—Rash—Triamcinolone—multiple sclerosis	9.43e-05	0.000439	CcSEcCtD
Etoricoxib—Dermatitis—Triamcinolone—multiple sclerosis	9.42e-05	0.000439	CcSEcCtD
Etoricoxib—Anorexia—Methotrexate—multiple sclerosis	9.42e-05	0.000438	CcSEcCtD
Etoricoxib—Rash—Methylprednisolone—multiple sclerosis	9.41e-05	0.000438	CcSEcCtD
Etoricoxib—Dermatitis—Methylprednisolone—multiple sclerosis	9.4e-05	0.000438	CcSEcCtD
Etoricoxib—Urticaria—Prednisone—multiple sclerosis	9.39e-05	0.000437	CcSEcCtD
Etoricoxib—Headache—Triamcinolone—multiple sclerosis	9.37e-05	0.000436	CcSEcCtD
Etoricoxib—Headache—Methylprednisolone—multiple sclerosis	9.35e-05	0.000435	CcSEcCtD
Etoricoxib—Abdominal pain—Prednisone—multiple sclerosis	9.34e-05	0.000435	CcSEcCtD
Etoricoxib—Diarrhoea—Betamethasone—multiple sclerosis	9.29e-05	0.000432	CcSEcCtD
Etoricoxib—Diarrhoea—Dexamethasone—multiple sclerosis	9.29e-05	0.000432	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9e-05	0.000419	CcSEcCtD
Etoricoxib—Dizziness—Dexamethasone—multiple sclerosis	8.97e-05	0.000418	CcSEcCtD
Etoricoxib—Dizziness—Betamethasone—multiple sclerosis	8.97e-05	0.000418	CcSEcCtD
Etoricoxib—Insomnia—Methotrexate—multiple sclerosis	8.93e-05	0.000416	CcSEcCtD
Etoricoxib—Nausea—Triamcinolone—multiple sclerosis	8.88e-05	0.000414	CcSEcCtD
Etoricoxib—Nausea—Methylprednisolone—multiple sclerosis	8.86e-05	0.000413	CcSEcCtD
Etoricoxib—Dyspnoea—Methotrexate—multiple sclerosis	8.81e-05	0.00041	CcSEcCtD
Etoricoxib—Somnolence—Methotrexate—multiple sclerosis	8.78e-05	0.000409	CcSEcCtD
Etoricoxib—Hypersensitivity—Prednisone—multiple sclerosis	8.71e-05	0.000406	CcSEcCtD
Etoricoxib—Dyspepsia—Methotrexate—multiple sclerosis	8.69e-05	0.000405	CcSEcCtD
Etoricoxib—Vomiting—Dexamethasone—multiple sclerosis	8.63e-05	0.000402	CcSEcCtD
Etoricoxib—Vomiting—Betamethasone—multiple sclerosis	8.63e-05	0.000402	CcSEcCtD
Etoricoxib—Decreased appetite—Methotrexate—multiple sclerosis	8.59e-05	0.0004	CcSEcCtD
Etoricoxib—Rash—Betamethasone—multiple sclerosis	8.56e-05	0.000398	CcSEcCtD
Etoricoxib—Rash—Dexamethasone—multiple sclerosis	8.56e-05	0.000398	CcSEcCtD
Etoricoxib—Dermatitis—Dexamethasone—multiple sclerosis	8.55e-05	0.000398	CcSEcCtD
Etoricoxib—Dermatitis—Betamethasone—multiple sclerosis	8.55e-05	0.000398	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Methotrexate—multiple sclerosis	8.53e-05	0.000397	CcSEcCtD
Etoricoxib—Fatigue—Methotrexate—multiple sclerosis	8.52e-05	0.000397	CcSEcCtD
Etoricoxib—Headache—Betamethasone—multiple sclerosis	8.5e-05	0.000396	CcSEcCtD
Etoricoxib—Headache—Dexamethasone—multiple sclerosis	8.5e-05	0.000396	CcSEcCtD
Etoricoxib—Asthenia—Prednisone—multiple sclerosis	8.48e-05	0.000395	CcSEcCtD
Etoricoxib—Pain—Methotrexate—multiple sclerosis	8.45e-05	0.000393	CcSEcCtD
Etoricoxib—Pruritus—Prednisone—multiple sclerosis	8.36e-05	0.000389	CcSEcCtD
Etoricoxib—Feeling abnormal—Methotrexate—multiple sclerosis	8.14e-05	0.000379	CcSEcCtD
Etoricoxib—Diarrhoea—Prednisone—multiple sclerosis	8.09e-05	0.000377	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.08e-05	0.000376	CcSEcCtD
Etoricoxib—Nausea—Betamethasone—multiple sclerosis	8.06e-05	0.000375	CcSEcCtD
Etoricoxib—Nausea—Dexamethasone—multiple sclerosis	8.06e-05	0.000375	CcSEcCtD
Etoricoxib—Urticaria—Methotrexate—multiple sclerosis	7.85e-05	0.000365	CcSEcCtD
Etoricoxib—Dizziness—Prednisone—multiple sclerosis	7.82e-05	0.000364	CcSEcCtD
Etoricoxib—Abdominal pain—Methotrexate—multiple sclerosis	7.81e-05	0.000364	CcSEcCtD
Etoricoxib—Vomiting—Prednisone—multiple sclerosis	7.51e-05	0.00035	CcSEcCtD
Etoricoxib—Rash—Prednisone—multiple sclerosis	7.45e-05	0.000347	CcSEcCtD
Etoricoxib—Dermatitis—Prednisone—multiple sclerosis	7.44e-05	0.000347	CcSEcCtD
Etoricoxib—Headache—Prednisone—multiple sclerosis	7.4e-05	0.000345	CcSEcCtD
Etoricoxib—Hypersensitivity—Methotrexate—multiple sclerosis	7.28e-05	0.000339	CcSEcCtD
Etoricoxib—Asthenia—Methotrexate—multiple sclerosis	7.09e-05	0.00033	CcSEcCtD
Etoricoxib—Nausea—Prednisone—multiple sclerosis	7.02e-05	0.000327	CcSEcCtD
Etoricoxib—Pruritus—Methotrexate—multiple sclerosis	6.99e-05	0.000325	CcSEcCtD
Etoricoxib—Diarrhoea—Methotrexate—multiple sclerosis	6.76e-05	0.000315	CcSEcCtD
Etoricoxib—Dizziness—Methotrexate—multiple sclerosis	6.53e-05	0.000304	CcSEcCtD
Etoricoxib—Vomiting—Methotrexate—multiple sclerosis	6.28e-05	0.000292	CcSEcCtD
Etoricoxib—Rash—Methotrexate—multiple sclerosis	6.23e-05	0.00029	CcSEcCtD
Etoricoxib—Dermatitis—Methotrexate—multiple sclerosis	6.22e-05	0.00029	CcSEcCtD
Etoricoxib—Headache—Methotrexate—multiple sclerosis	6.19e-05	0.000288	CcSEcCtD
Etoricoxib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.13e-05	0.000449	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—multiple sclerosis	6.11e-05	0.000447	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—PABPC1—multiple sclerosis	6.1e-05	0.000447	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	6.07e-05	0.000444	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MX1—multiple sclerosis	6.07e-05	0.000444	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—multiple sclerosis	6.05e-05	0.000443	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	6.04e-05	0.000443	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—multiple sclerosis	6.01e-05	0.00044	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DRA—multiple sclerosis	5.87e-05	0.00043	CbGpPWpGaD
Etoricoxib—Nausea—Methotrexate—multiple sclerosis	5.87e-05	0.000273	CcSEcCtD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.84e-05	0.000428	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.84e-05	0.000428	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—IL6—multiple sclerosis	5.76e-05	0.000422	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	5.73e-05	0.000419	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	5.72e-05	0.000419	CbGpPWpGaD
Etoricoxib—CYP2E1—Biological oxidations—POMC—multiple sclerosis	5.69e-05	0.000417	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.68e-05	0.000416	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—IL6—multiple sclerosis	5.68e-05	0.000416	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—MAPK1—multiple sclerosis	5.67e-05	0.000415	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.67e-05	0.000415	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—S1PR1—multiple sclerosis	5.66e-05	0.000414	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—MAPK1—multiple sclerosis	5.62e-05	0.000411	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—TYK2—multiple sclerosis	5.6e-05	0.00041	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—MYC—multiple sclerosis	5.58e-05	0.000408	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	5.57e-05	0.000408	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TGFB1—multiple sclerosis	5.56e-05	0.000407	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.56e-05	0.000407	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NOD1—multiple sclerosis	5.54e-05	0.000405	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—STAT3—multiple sclerosis	5.53e-05	0.000405	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—RPL5—multiple sclerosis	5.5e-05	0.000403	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GPC5—multiple sclerosis	5.5e-05	0.000403	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—MAPK1—multiple sclerosis	5.46e-05	0.0004	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—multiple sclerosis	5.42e-05	0.000397	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MALT1—multiple sclerosis	5.35e-05	0.000392	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.29e-05	0.000388	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.29e-05	0.000388	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IRF5—multiple sclerosis	5.26e-05	0.000385	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TNF—multiple sclerosis	5.19e-05	0.00038	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD86—multiple sclerosis	5.19e-05	0.00038	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—STAT3—multiple sclerosis	5.1e-05	0.000373	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2RA—multiple sclerosis	5.04e-05	0.000369	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.03e-05	0.000369	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—MAPK1—multiple sclerosis	5.03e-05	0.000368	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-G—multiple sclerosis	5.03e-05	0.000368	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IRF8—multiple sclerosis	5.03e-05	0.000368	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFIH1—multiple sclerosis	5.03e-05	0.000368	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—GPC5—multiple sclerosis	5.02e-05	0.000368	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.02e-05	0.000368	CbGpPWpGaD
Etoricoxib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.97e-05	0.000364	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.92e-05	0.000361	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	4.88e-05	0.000357	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—HLA-B—multiple sclerosis	4.84e-05	0.000354	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—IL6—multiple sclerosis	4.82e-05	0.000353	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RGS1—multiple sclerosis	4.81e-05	0.000352	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SRM—multiple sclerosis	4.74e-05	0.000347	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	4.73e-05	0.000346	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	4.71e-05	0.000345	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TNFAIP3—multiple sclerosis	4.71e-05	0.000345	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.69e-05	0.000343	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	4.63e-05	0.000339	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	4.62e-05	0.000339	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP27B1—multiple sclerosis	4.6e-05	0.000337	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP24A1—multiple sclerosis	4.6e-05	0.000337	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GPR65—multiple sclerosis	4.56e-05	0.000334	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.49e-05	0.000329	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	4.49e-05	0.000329	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	4.47e-05	0.000327	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	4.4e-05	0.000322	CbGpPWpGaD
Etoricoxib—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.39e-05	0.000322	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.38e-05	0.000321	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SRM—multiple sclerosis	4.36e-05	0.000319	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—PGR—multiple sclerosis	4.33e-05	0.000317	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	4.33e-05	0.000317	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	4.33e-05	0.000317	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SRM—multiple sclerosis	4.32e-05	0.000316	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD28—multiple sclerosis	4.23e-05	0.00031	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GPC5—multiple sclerosis	4.21e-05	0.000308	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—STAT3—multiple sclerosis	4.18e-05	0.000306	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL13—multiple sclerosis	4.17e-05	0.000305	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR1—multiple sclerosis	4.17e-05	0.000305	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTPRC—multiple sclerosis	4.16e-05	0.000304	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CCR2—multiple sclerosis	4.16e-05	0.000304	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TLR4—multiple sclerosis	4.1e-05	0.0003	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—POMC—multiple sclerosis	4.04e-05	0.000296	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DPB1—multiple sclerosis	4.02e-05	0.000294	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.01e-05	0.000293	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GPC5—multiple sclerosis	3.96e-05	0.00029	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—STAT3—multiple sclerosis	3.92e-05	0.000287	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD40—multiple sclerosis	3.87e-05	0.000283	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ITGA4—multiple sclerosis	3.87e-05	0.000283	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—multiple sclerosis	3.86e-05	0.000283	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNB1—multiple sclerosis	3.84e-05	0.000281	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTLA4—multiple sclerosis	3.81e-05	0.000279	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—MAPK1—multiple sclerosis	3.8e-05	0.000278	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD80—multiple sclerosis	3.78e-05	0.000277	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SRM—multiple sclerosis	3.69e-05	0.00027	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—ALB—multiple sclerosis	3.64e-05	0.000267	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TYK2—multiple sclerosis	3.62e-05	0.000265	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—MAPK1—multiple sclerosis	3.56e-05	0.000261	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	3.56e-05	0.000261	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	3.55e-05	0.00026	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—RRM1—multiple sclerosis	3.48e-05	0.000255	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.42e-05	0.000251	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—VCAM1—multiple sclerosis	3.36e-05	0.000246	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DQA1—multiple sclerosis	3.35e-05	0.000246	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.34e-05	0.000245	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.34e-05	0.000245	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—RRM1—multiple sclerosis	3.28e-05	0.00024	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—RPL5—multiple sclerosis	3.27e-05	0.000239	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.26e-05	0.000239	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.22e-05	0.000235	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.21e-05	0.000235	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TYK2—multiple sclerosis	3.19e-05	0.000234	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.15e-05	0.00023	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DQB1—multiple sclerosis	3.14e-05	0.00023	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SLC11A1—multiple sclerosis	3.13e-05	0.000229	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.07e-05	0.000225	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.07e-05	0.000225	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.05e-05	0.000224	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.05e-05	0.000223	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.05e-05	0.000223	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—VDR—multiple sclerosis	3.03e-05	0.000222	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD86—multiple sclerosis	3.02e-05	0.000221	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.99e-05	0.000219	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.98e-05	0.000218	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL3—multiple sclerosis	2.97e-05	0.000218	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD40LG—multiple sclerosis	2.96e-05	0.000217	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2—multiple sclerosis	2.95e-05	0.000216	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD8A—multiple sclerosis	2.93e-05	0.000215	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—multiple sclerosis	2.92e-05	0.000214	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD4—multiple sclerosis	2.89e-05	0.000212	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTGER4—multiple sclerosis	2.86e-05	0.00021	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SRM—multiple sclerosis	2.85e-05	0.000209	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MMP9—multiple sclerosis	2.85e-05	0.000209	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-B—multiple sclerosis	2.82e-05	0.000206	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PGR—multiple sclerosis	2.82e-05	0.000206	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.81e-05	0.000206	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.79e-05	0.000204	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCR3—multiple sclerosis	2.76e-05	0.000202	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—multiple sclerosis	2.74e-05	0.000201	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CD28—multiple sclerosis	2.74e-05	0.0002	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.7e-05	0.000198	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR2—multiple sclerosis	2.69e-05	0.000197	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.64e-05	0.000193	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2RA—multiple sclerosis	2.64e-05	0.000193	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-A—multiple sclerosis	2.61e-05	0.000191	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.6e-05	0.000191	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.6e-05	0.000191	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.54e-05	0.000186	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—STAT3—multiple sclerosis	2.53e-05	0.000185	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.53e-05	0.000185	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD28—multiple sclerosis	2.5e-05	0.000183	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CNR1—multiple sclerosis	2.48e-05	0.000182	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR4—multiple sclerosis	2.39e-05	0.000175	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DRB1—multiple sclerosis	2.39e-05	0.000175	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.38e-05	0.000174	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TGFB1—multiple sclerosis	2.35e-05	0.000172	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.33e-05	0.00017	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.32e-05	0.00017	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.31e-05	0.000169	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TGFB1—multiple sclerosis	2.3e-05	0.000169	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MAPK1—multiple sclerosis	2.3e-05	0.000169	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ICAM1—multiple sclerosis	2.29e-05	0.000168	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—MAPK1—multiple sclerosis	2.26e-05	0.000165	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL10—multiple sclerosis	2.23e-05	0.000164	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD80—multiple sclerosis	2.2e-05	0.000161	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—multiple sclerosis	2.19e-05	0.000161	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.12e-05	0.000155	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—MAPK1—multiple sclerosis	2.03e-05	0.000149	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.01e-05	0.000147	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.01e-05	0.000147	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—BCHE—multiple sclerosis	2e-05	0.000147	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.97e-05	0.000144	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.96e-05	0.000144	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CD86—multiple sclerosis	1.95e-05	0.000143	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL5—multiple sclerosis	1.92e-05	0.000141	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.88e-05	0.000138	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TYK2—multiple sclerosis	1.86e-05	0.000136	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.84e-05	0.000134	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.79e-05	0.000131	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD86—multiple sclerosis	1.78e-05	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SPP1—multiple sclerosis	1.78e-05	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—multiple sclerosis	1.77e-05	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNG—multiple sclerosis	1.74e-05	0.000128	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR5—multiple sclerosis	1.73e-05	0.000127	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2RA—multiple sclerosis	1.71e-05	0.000125	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.69e-05	0.000124	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—multiple sclerosis	1.68e-05	0.000123	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CCR5—multiple sclerosis	1.58e-05	0.000116	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—APOE—multiple sclerosis	1.58e-05	0.000115	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—multiple sclerosis	1.56e-05	0.000114	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—multiple sclerosis	1.55e-05	0.000114	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2—multiple sclerosis	1.55e-05	0.000113	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HLA-A—multiple sclerosis	1.54e-05	0.000113	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.54e-05	0.000113	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.54e-05	0.000113	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.53e-05	0.000112	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.52e-05	0.000111	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.45e-05	0.000106	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APOE—multiple sclerosis	1.44e-05	0.000105	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CD80—multiple sclerosis	1.42e-05	0.000104	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.4e-05	0.000103	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—POMC—multiple sclerosis	1.35e-05	9.91e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.34e-05	9.79e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.33e-05	9.71e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL2—multiple sclerosis	1.32e-05	9.7e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.31e-05	9.62e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—STAT3—multiple sclerosis	1.3e-05	9.54e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD80—multiple sclerosis	1.3e-05	9.52e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—APOE—multiple sclerosis	1.2e-05	8.82e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MYC—multiple sclerosis	1.2e-05	8.81e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TYK2—multiple sclerosis	1.2e-05	8.81e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.2e-05	8.77e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK1—multiple sclerosis	1.18e-05	8.67e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—APOE—multiple sclerosis	1.13e-05	8.3e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.13e-05	8.29e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TYK2—multiple sclerosis	1.1e-05	8.04e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—POMC—multiple sclerosis	1.03e-05	7.57e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—multiple sclerosis	1e-05	7.33e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—multiple sclerosis	9.92e-06	7.27e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—POMC—multiple sclerosis	9.74e-06	7.13e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—multiple sclerosis	9.47e-06	6.94e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—multiple sclerosis	9.43e-06	6.91e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—multiple sclerosis	9.1e-06	6.66e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—multiple sclerosis	8.88e-06	6.5e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—APOE—multiple sclerosis	8.74e-06	6.4e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.74e-06	6.4e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT3—multiple sclerosis	8.42e-06	6.17e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—APOE—multiple sclerosis	8.04e-06	5.89e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—APOE—multiple sclerosis	7.97e-06	5.84e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MYC—multiple sclerosis	7.83e-06	5.73e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—multiple sclerosis	7.81e-06	5.72e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—STAT3—multiple sclerosis	7.68e-06	5.63e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK1—multiple sclerosis	7.66e-06	5.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—POMC—multiple sclerosis	7.51e-06	5.5e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MYC—multiple sclerosis	7.14e-06	5.23e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—multiple sclerosis	7.12e-06	5.22e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MAPK1—multiple sclerosis	6.98e-06	5.11e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—POMC—multiple sclerosis	6.91e-06	5.06e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—POMC—multiple sclerosis	6.85e-06	5.02e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—multiple sclerosis	6.85e-06	5.02e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—APOE—multiple sclerosis	6.81e-06	4.99e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—multiple sclerosis	6.3e-06	4.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—multiple sclerosis	6.24e-06	4.57e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—multiple sclerosis	5.88e-06	4.31e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—POMC—multiple sclerosis	5.85e-06	4.29e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—multiple sclerosis	5.37e-06	3.93e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—multiple sclerosis	5.34e-06	3.91e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APOE—multiple sclerosis	5.26e-06	3.85e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—POMC—multiple sclerosis	4.52e-06	3.31e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—multiple sclerosis	4.12e-06	3.02e-05	CbGpPWpGaD
